• <blockquote id="sqo4s"></blockquote>
  • <rt id="sqo4s"><kbd id="sqo4s"></kbd></rt>
  • <td id="sqo4s"></td>
    Food & Food Contact Materials
    CIRS Group
    Chemicals
    Food
    Cosmetic
    Medical Devices
    Agrochemicals
    Biocide
    Carbon Neutrality
    Testing
    Search

    EU Novel Food Application Updates in Q4 2025

    from CIRS by

    CIRS has conducted a statistical analysis on the approval trends of Novel Food (hereinafter referred to as NF) in the EU in the fourth quarter of 2025. This is according to public information from the EU information retrieval platform Open EFSA, as of December 31, 2025.

    The summary is shown in the following table:

    Table 1: NF approval status in the EU in Q4 2025

    European Commission (EC)

    Approval

    3

    European Food Safety Authority (EFSA)

    Received dossiers

    6

    Validated dossiers

    4

    Published scientific opinions

    2

    Approved substances

    In the fourth quarter of 2025, EC authorized a total of three substances, including two new novel food applications and one modification application for authorised NF.

    Table 2: Substances approved by the EU in Q4 2025

    Number

    Substance

    Type of Application

    Date of Authorisation

    Applicant

    1

    Clostridium butyricum TO-A

    New NF

    2025.11.06

    TOA Biopharma Co. Ltd.

    2

    Yellow tomato extract

    New NF

    2025.11.07

    Lycored Ltd

    3

    Schizochytrium sp. (ATCC PTA-9695) oil 

    Modification

    2025.11.07

    DSM Nutritional Products Europe Ltd.

    Received dossiers

    In the fourth quarter of 2025, EFSA received a total of nine applications, including seven NF applications, and two modification applications for authorised NF.

    Table 3: Substances for which application dossiers were received by the EFSA in Q4 2025

    Number

    Substance

    Type of application

    Received date

    Applicant

    1

    Egg Yolk Protein Extract

    New NF

    2025.10.01

    IGY Immune Tech. & Life Sciences

    2

    Pyrroloquinoline quinone disodium salt (PQQ)

    Modification

    2025.10.09

    Compendium GmbH

    3

    Defatted Passion Fruit Seed Extract 

    New NF

    2025.10.14

    ALIDANS Srl

    4

    (1-carbamoyl-2-phenyl-ethyl) butyramide

    New NF

    2025.11.12

    RHEA Innovation Srl

    5

    Gamma -Aminobutyric acid

    New NF

    2025.11.13

    Bloomage Biotechnology Corporation Limited

    6

    Schizochytrium sp. (LU310) oil

    New NF

    2025.11.18

    LinYi YouKang Biology Co., Ltd

    7

    Ginger oleoresin obtained by CO2 supercritical extraction

    New NF

    2025.12.10

    Givaudan International SA

    8

    Coffee fruit extract

    New NF

    2025.12.16

    VDF FutureCeuticals, Inc.

    9

    2’-Fucosyllactose (2’-FL) 

    Modification

    2025.12.17

    珠海市朗健生物科技有限公司

    18

    Egg Yolk Protein Extract

    New NF

    2025.10.01

    IGY Immune Tech. & Life Sciences

    Validated dossiers

    In the fourth quarter of 2025, EFSA validated a total of four applications, including one NF application and three modification applications for authorised NF.

    Table 4: Substances for which application dossiers were validated by the EFSA in Q4 2025

    Number

    Substance

    Type of application

    Validated date

    Applicant

    1

    Egg membrane hydrolysate

    Modification

    2025.10.06

    Eggnovo SL

    2

    Chitin-glucan from Aspergillus niger

    Modification

    2025.10.10

    KITOZYME

    3

    Ubiquinol acetate

    New NF

    2025.11.13

    Vita Actives Limited

    4

    2’-Fucosyllactose (2’-FL)

    Modification

    2025.11.14

    虹摹生物科技(上海)有限公司

    Published scientific opinions

    In the fourth quarter of 2025, EFSA published its scientific opinions on one NF application.

    Table 5: Substances for which the EFSA published its scientific opinions in Q4 2025

    Number

    Substance

    Conclusions

    Type of application

    Publication date

    Applicant

    1

    Galacto-oligosaccharide (GOS)

    The applicant proposed to extend the use of GOS to several food categories (non-alcoholic beverages, confectionery, chewing gum, cocoa and chocolate-based products and protein products). The target population is the general population.

    The EFSA Panel concludes that the proposed extension of use of GOS is safe under the proposed conditions of use.

    Modification

    2025.12.16

    FrieslandCampina Nederland B.V.

    About CIRS

    The Food Business Division of CIRS Group, established in 2012, has successfully assisted over 1,000 domestic and international food and feed companies in achieving "one-stop" regulatory compliance. Leveraging our extensive expertise and resources across multiple jurisdictions, we provide comprehensive compliance solutions including:

    • China - “Three New” Food Registration: new food material, new food additives, and new food contact materials (including synthetic biology-derived products)
    • China - New Feed and New Feed Additive Application
    • US - FDA GRAS Notice
    • US - Animal Food GRAS Conclusions
    • EU - Novel Food Application
    • EU - Food Enzyme (Food Enzyme Preparation) Application
    • EU - Food Additive Application
    • EU - Feed Additive Application

    If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

      

    We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

    Contact Us
    +353 1 477 3710 (EU)
    +44 20 3239 9430 (UK)
    +1 703 520 1420 (USA)
    +86 571 8720 6574 (CN)
    +82 2 6347 8816 (KR)
    +81 070-9365-8022 (JP)
  • <blockquote id="sqo4s"></blockquote>
  • <rt id="sqo4s"><kbd id="sqo4s"></kbd></rt>
  • <td id="sqo4s"></td>
    丝瓜视频